Stifel analyst Laura Prendergast reiterated a Buy rating and $48.00 price target on Olema Pharmaceuticals (NASDAQ: OLMA).The analyst comments "Today ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE